Clinical trial

The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study

NCT05090267

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-06-01

PhaseNA

Study timeline

Study start (actual)2022-06-01Date precision: day

Registry last updated2026-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cognitionunresolved

Gut Microbiomeunresolved

Interventions

Probiotic SupplementDIETARY_SUPPLEMENT

Transcutaneous Vagal Nerve Stimulation (tVNS)DEVICE

Sponsors & collaborators

University of Floridalead sponsor

University of Miamicollaborator

University of Louisvillecollaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator

Exegi Pharma, LLCcollaborator

Soterix Medicalcollaborator

Mapped research locations

Coral GablesFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05090267 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.